Verici Dx plc (AIM:VRCI)
London · Delayed Price · Currency is GBP · Price in GBX 0.2250
0.00 (0.00%)
Sep 11, 2026, 3:44 PM GMT
Verici Dx Market Cap
Verici Dx has a market cap or net worth of 5.15 million as of September 11, 2026. Its market cap has decreased by -35.23% in one year.
Market Cap
5.15M
Enterprise Value
2.81M
Revenue
2.72M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.23
ChartMarket Cap Chart
Since November 3, 2020, Verici Dx's market cap has decreased from 51.74M to 5.15M, a decrease of -90.05%. That is a compound annual growth rate of -32.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 5.15M | -53.10% |
| Dec 31, 2025 | 10.97M | 16.74% |
| Dec 31, 2024 | 9.40M | -43.40% |
| Dec 29, 2023 | 16.61M | -22.00% |
| Dec 30, 2022 | 21.29M | -71.66% |
| Dec 31, 2021 | 75.13M | -9.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 182.37B |
| GSK plc | 70.94B |
| Haleon | 29.40B |
| Smith & Nephew | 8.63B |
| GENinCode | 6.40M |
| Cizzle Biotechnology Holdings | 6.37M |
| CRISM Therapeutics | 6.10M |
| Theracryf | 5.05M |